Incidence and clinical features of cerebrovascular disease among HIV-infected adults in the southeastern United States

AIDS Research and Human Retroviruses

Volumn 29, Issue 7, 2013, Pages 1068-1074

  Vinikoor, Michael J ^a   Napravnik, Sonia ^a,b   Floris Moore, Michelle ^a   Wilson, Susan ^a   Huang, David Y ^a   Eron, Joseph J ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b University of North Carolina at Chapel Hill   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS RNA;

ADULT; ANTIVIRAL THERAPY; ARTICLE; ATHEROSCLEROSIS; BRAIN HEMORRHAGE; BRAIN INJURY; BRAIN ISCHEMIA; CD4 LYMPHOCYTE COUNT; CEREBROVASCULAR ACCIDENT; CEREBROVASCULAR DISEASE; CLINICAL FEATURE; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DYSLIPIDEMIA; FEMALE; FOLLOW UP; HEPATITIS C; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HYPERTENSION; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MIXED INFECTION; MORTALITY; PRIORITY JOURNAL; RISK FACTOR; TRANSIENT ISCHEMIC ATTACK; UNITED STATES; VIRUS LOAD; WHITE MATTER LESION;

ADULT; CEREBROVASCULAR DISORDERS; COHORT STUDIES; FEMALE; HIV INFECTIONS; HUMANS; INCIDENCE; MALE; MIDDLE AGED; NORTH CAROLINA; RISK FACTORS; SOUTHEASTERN UNITED STATES; STROKE;

EID: 84879131663     PISSN: 08892229     EISSN: 19318405     Source Type: Journal    
DOI: 10.1089/aid.2012.0334     Document Type: Article

References (39)

1. Achhra AC, Amin J, Law MG, et al.: Immunodeficiency and risk of serious clinical endpoints in a well studied cohort of treated HIV-infected patients. AIDS 2010;24:1877-1886.
2. Sackoff JE, Hanna DB, Pfeiffer MR, et al.: Causes of death among persons with AIDS in the era of highly active antiretroviral therapy: New York City. Ann Intern Med 2006; 145:397-406.
3. Triant VA, Lee H, Hadigan C, et al.: Increased acute myocardial infarction rates and cardiovascular risk factors among patients with human immunodeficiency virus disease. J Clin Endocrinol Metab 2007;92:2506-2512.
4. Bukrinsky M and Sviridov D: HIV and cardiovascular disease: Contribution of HIV-infected macrophages to development of atherosclerosis. PLoS Med 2007;4:e43.
5. Eugenin EA, Morgello S, Klotman ME, et al.: Human immunodeficiency virus (HIV) infects human arterial smooth muscle cells in vivo and in vitro: Implications for the pathogenesis of HIV-mediated vascular disease. Am J Pathol 2008;172:1100-1111.
6. Brown TT, Cole SR, Li X, et al.: Antiretroviral therapy and the prevalence and incidence of diabetes mellitus in the multicenter AIDS cohort study. Arch Intern Med 2005;165:1179-1184.
7. Friis-Møller N,Weber R, Reiss P, et al.: Cardiovascular disease risk factors in HIV patients-association with antiretroviral therapy.Results fromtheDADstudy.AIDS 2003;17:1179-1193.
8. Tipping B, de Villiers L, Wainwright H, et al.: Stroke in patients with human immunodeficiency virus infection. J Neurol Neurosurg Psychiatry 2007;78:1320-1324.
9. Ortiz G, Koch S, Romano JG, et al.: Mechanisms of ischemic stroke in HIV-infected patients. Neurology 2007;68:1257-1261.
10. Connor MD, Lammie GA, Bell JE, et al.: Cerebral infarction in adult AIDS patients: Observations from the Edinburgh HIV autopsy cohort. Stroke 2000;31:2117-2126.
11. Pinto AN: AIDS and cerebrovascular disease. Stroke. 1996;27:538-543.
12. d'Armihio Monforte A, Cinque P, Mocroft A, et al.: Changing incidence of central nervous system diseases in the EuroSIDA cohort. Ann Neurol 2004;55:320-328.
13. Ovbiagele B and Nath A: Increasing incidence of ischemic stroke in patients with HIV infection. Neurology 2011;76:444-450.
14. Rasmussen LD, Engsig FN, Christensen H, et al.: Risk of cerebrovascular events in persons with and without HIV: A Danish nationwide population-based cohort study. AIDS 2011;25:1637-1646.
15. Chow FC, Regan S, Feske S, et al.: Comparison of ischemic stroke incidence in HIV-infected and non-HIV-infected patients in a US health care system. J Acquir Immune Defic Syndr 2012;60:351-358.
16. Casper ML, Barnette E, Williams GIJ, et al.: Atlas of Stroke Mortality: Racial, Ethnic, and Geographic Disparities in the United States. Center for Disease Control and Prevention, 2003.
17. Centers for Disease Control and Prevention: HIV Surveillance Report, 2009, 2011.
18. Napravnik S, Eron JJ Jr., McKaig RG, et al.: Factors associated with fewer visits for HIV primary care at a tertiary care center in the Southeastern U.S. AIDS Care 2006; 18 Suppl 1:S45-50.
19. The World Health Organization MONICA Project (monitoring trends and determinants of cardiovascular disease): A major international collaboration. WHO MONICA Principal Investigators. J Clin Epidemiol 1988;41:105-114.
20. Easton JD, Saver JL, Albers GW, et al.: Definition and evaluation of transient ischemic attack. Stroke 2009;40:2276-2293.
21. Adams HP Jr, Bendixen BH, Kappelle LJ, et al.: Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. Stroke 1993;24:35-41.
22. Rosamond WD, Folsom AR, Chambless LE, et al.: Stroke incidence and survival among middle-aged adults: 9-year follow-up of the atherosclerosis risk in communities (ARIC) cohort. Stroke 1999;30:736-743.
23. Levey AS, Bosch JP, Lewis JB, et al.: A more accurate method to estimate glomerular filtration from serum creatinine: A new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 1999;130:461-470.
24. Levey AS, Eckardt K, Tsukamoto Y, et al.: Definition and classification of chronic kidney disease: A position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int 2005;67:2089-2100.
25. Writing committee of the D:A:D study group: Cardio-and cerebrovascular events in HIV-infected persons. AIDS 2004;18:1811-1817.
26. Corral I, Quereda C, Moreno A, et al.: Cerebrovascular ischemic events in HIV-1-infected patients receiving highly active antiretroviral therapy: Incidence and risk factors. Cerebrovasc Dis 2009;27:559-563.
27. Truelsen T, Piechowski-Jozwiak B, Bonita R, et al.: Stroke incidence and prevalence in Europe: A review of available data. Eur J Neurol 2006;13:581-598.
28. Sico J, Chang J, Freiberg M, et al.: HIV infection, hepatitis C infection, and risk of stroke in the veterans aging cohort study virtual cohort (VACS-VC). Paper presented at the Conference on Retroviruses and Opportunistic Infections, 2010.
29. Leibson CL, Naessens JM, Brown RD, et al.: Accuracy of hospital discharge abstracts for identifying stroke. Stroke 1994;25:2348-2355.
30. National Heart Lung and Blood Institute: Incidence and Prevalence: 2006 Chart Book on Cardiovascular and Lung Diseases. Bethesda, Maryland, 2006.
31. The antiretroviral therapy cohort collaboration (ART-CC writing committee): Causes of death in HIV-1 infected patients treated with antiretroviral therapy, 1996-2006: Collaborative analysis of 13 HIV cohort studies. Clin Infect Dis 2010;50:1387-1396.
32. Marin B, Thiebaut R, Bucher HC, et al.: Non-AIDS-defining deaths and immunodeficiency in the era of combination antiretroviral therapy. AIDS 2009;13:1743-1753.
33. El-Sadr WM, Lundgren JD, Neaton JD, et al.: CD4 + countguided interruption of antiretroviral treatment. N Engl J Med 2006;355:2283-2296.
34. Zhang S, van Sighem A, Kesserling A, et al.: Episodes of HIV viremia and the risk of non-AIDS diseases in patients on suppressive antiretroviral therapy. J Acquir Immune Defic Syndr 2012;60:265-272.
35. Panel on antiretroviral guidelines for adults and adolescents: Guidelines for the Use of Antiretroviral Agents in HIV-1 Infected Adults and Adolescents. Department of Health and Human Services, 2012.
36. Friis-Møller N, Sabin CA, Weber R, et al.: Combination antiretroviral therapy and the risk of myocardial infarction. N Engl J Med 2003;349:1993-2003.
37. Periard D, Telenti A, Sudre P, et al.: Atherogenic dyslipidemia in HIV-infected individuals treated with protease inhibitors. The Swiss HIV Cohort Study. Circulation 1999;100: 700-705.
38. Lifson AR, INSIGHT Endpoint Review Committee Writing Group, Belloso WH, et al.: Development of diagnostic criteria for serious non-AIDS events in HIV clinical trials. HIV Clin Trials 2010;11:205-219.
39. Goldstein LB: Accuracy of ICD-9-CM coding for the identification of patients with acute ischemic stroke: Effect of modifier codes. Stroke 1998;29:1602-1604.